Skip to main content
Top
Published in: Nuclear Medicine and Molecular Imaging 4/2016

01-12-2016 | Case Report

Giant Cell Tumor with Secondary Aneurysmal Bone Cyst Shows Heterogeneous Metabolic Pattern on 18F-FDG PET/CT: A Case Report

Authors: Hee Jeong Park, Seong Young Kwon, Sang-Geon Cho, Jahae Kim, Ho-Chun Song, Sung Sun Kim, Yeon Hong Yoon, Jin Gyoon Park

Published in: Nuclear Medicine and Molecular Imaging | Issue 4/2016

Login to get access

Abstract

Giant cell tumor (GCT) is a generally benign bone tumor accounting for approximately 5 % of all primary bone neoplasms. Cystic components in GCTs that indicate secondary aneurysmal bone cysts (ABCs) are reported in 14 % of GCTs. Although both of them have been described separately in previous reports that may show considerable fluorodeoxyglucose (FDG) uptake despite their benign nature, the findings of GCT with secondary ABC on 18F-FDG positron emission tomography/computed tomography (PET/CT) have not been well-known. We report a case of GCT with secondary ABC in a 26-year-old woman. 18F-FDG PET/CT revealed a heterogeneous hypermetabolic lesion in the left proximal femur with the maximum standardized uptake value of 4.7. The solid components of the tumor showed higher FDG uptake than the cystic components. These observations suggest that the ABC components in GCTs show heterogeneous metabolic patterns on 18F-FDG PET/CT.
Literature
1.
go back to reference Murphey MD, Nomikos GC, Flemming DJ, Gannon FH, Temple HT, Kransdorf MJ. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation. Radiographics. 2001;21:1283–309.CrossRefPubMed Murphey MD, Nomikos GC, Flemming DJ, Gannon FH, Temple HT, Kransdorf MJ. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation. Radiographics. 2001;21:1283–309.CrossRefPubMed
2.
go back to reference Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69:106–14.CrossRefPubMed Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69:106–14.CrossRefPubMed
3.
go back to reference Vincent J, Vigorita V. Bone cysts and giant-cell tumor. Orthopedic Pathology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2007. Vincent J, Vigorita V. Bone cysts and giant-cell tumor. Orthopedic Pathology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2007.
5.
go back to reference Sherwani RK, Zaheer S, Sabir AB, Goel S. Giant cell tumor along with secondary aneurysmal bone cyst of scapula: a rare presentation. Int J Shoulder Surg. 2008;2:59–61.CrossRefPubMedPubMedCentral Sherwani RK, Zaheer S, Sabir AB, Goel S. Giant cell tumor along with secondary aneurysmal bone cyst of scapula: a rare presentation. Int J Shoulder Surg. 2008;2:59–61.CrossRefPubMedPubMedCentral
6.
go back to reference Levine E, De Smet AA, Neff JR. Role of radiologic imaging in management planning of giant cell tumor of bone. Skeletal Radiol. 1984;12:79–89.CrossRefPubMed Levine E, De Smet AA, Neff JR. Role of radiologic imaging in management planning of giant cell tumor of bone. Skeletal Radiol. 1984;12:79–89.CrossRefPubMed
7.
go back to reference Van Nostrand D, Madewell JE, McNiesh LM, Kyle RW, Sweet D. Radionuclide bone scanning in giant cell tumor. J Nucl Med. 1986;27:329–38.PubMed Van Nostrand D, Madewell JE, McNiesh LM, Kyle RW, Sweet D. Radionuclide bone scanning in giant cell tumor. J Nucl Med. 1986;27:329–38.PubMed
8.
go back to reference Lichtenstein L. Aneurysmal bone cyst. A pathological entity commonly mistaken for giant-cell tumor and occasionally for hemangioma and osteogenic sarcoma. Cancer. 1950;3:279–89.CrossRef Lichtenstein L. Aneurysmal bone cyst. A pathological entity commonly mistaken for giant-cell tumor and occasionally for hemangioma and osteogenic sarcoma. Cancer. 1950;3:279–89.CrossRef
9.
go back to reference Unni KK, Inwards CY. Dahlin’s bone tumors: general aspects and data on 10,165 cases. Philadelphia: Lippincott Williams & Wilkins; 2010. Unni KK, Inwards CY. Dahlin’s bone tumors: general aspects and data on 10,165 cases. Philadelphia: Lippincott Williams & Wilkins; 2010.
10.
go back to reference Liu S, Jassim A, Bleeker J, Chen F, Kolanuvada B, Rong R, et al. Histopathological features of aneurysmal bone cyst of the temporal bone—a case report and review of literature. N A J Med Sci. 2015;8:46–9. Liu S, Jassim A, Bleeker J, Chen F, Kolanuvada B, Rong R, et al. Histopathological features of aneurysmal bone cyst of the temporal bone—a case report and review of literature. N A J Med Sci. 2015;8:46–9.
11.
12.
go back to reference Abdelwahab IF, Kenan S, Hermann G, Klein MJ, Lewis MM. Case report 845. Skeletal Radiol. 1994;23:317–9.CrossRefPubMed Abdelwahab IF, Kenan S, Hermann G, Klein MJ, Lewis MM. Case report 845. Skeletal Radiol. 1994;23:317–9.CrossRefPubMed
13.
go back to reference Pereira HM, Marchiori E, Severo A. Magnetic resonance imaging aspects of giant‐cell tumours of bone. J Med Imaging Radiat Oncol. 2014;58:674–8.CrossRefPubMed Pereira HM, Marchiori E, Severo A. Magnetic resonance imaging aspects of giant‐cell tumours of bone. J Med Imaging Radiat Oncol. 2014;58:674–8.CrossRefPubMed
14.
go back to reference Aoki J, Watanabe H, Shinozaki T, Takagishi K, Ishijima H, Oya N, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology. 2001;219:774–7.CrossRefPubMed Aoki J, Watanabe H, Shinozaki T, Takagishi K, Ishijima H, Oya N, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology. 2001;219:774–7.CrossRefPubMed
15.
go back to reference Aoki J, Endo K, Watanabe H, Shinozaki T, Yanagawa T, Ahmed AR, et al. FDG-PET for evaluating musculoskeletal tumors: a review. J Orthop Sci. 2003;8:435–41.CrossRefPubMed Aoki J, Endo K, Watanabe H, Shinozaki T, Yanagawa T, Ahmed AR, et al. FDG-PET for evaluating musculoskeletal tumors: a review. J Orthop Sci. 2003;8:435–41.CrossRefPubMed
16.
go back to reference Hoshi M, Takada J, Oebisu N, Hata K, Ieguchi M, Nakamura H. Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT. Arch Orthop Trauma Surg. 2012;132:1561–8.CrossRefPubMed Hoshi M, Takada J, Oebisu N, Hata K, Ieguchi M, Nakamura H. Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT. Arch Orthop Trauma Surg. 2012;132:1561–8.CrossRefPubMed
17.
go back to reference Folpe AL, Lyles RH, Sprouse JT, Conrad 3rd EU, Eary JF. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res. 2000;6:1279–87.PubMed Folpe AL, Lyles RH, Sprouse JT, Conrad 3rd EU, Eary JF. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res. 2000;6:1279–87.PubMed
18.
go back to reference Kubota K, Kubota R, Yamada S. FDG accumulation in tumor tissue. J Nucl Med. 1993;34:419–21.PubMed Kubota K, Kubota R, Yamada S. FDG accumulation in tumor tissue. J Nucl Med. 1993;34:419–21.PubMed
19.
go back to reference Schulte M, Brecht-Krauss D, Heymer B, Guhlmann A, Hartwig E, Sarkar MR, et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med. 2000;41:1695–701.PubMed Schulte M, Brecht-Krauss D, Heymer B, Guhlmann A, Hartwig E, Sarkar MR, et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med. 2000;41:1695–701.PubMed
20.
go back to reference Kole AC, Nieweg OE, Hoekstra HJ, van Horn JR. Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors. J Nucl Med. 1998;39:810–5.PubMed Kole AC, Nieweg OE, Hoekstra HJ, van Horn JR. Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors. J Nucl Med. 1998;39:810–5.PubMed
21.
go back to reference Higashi K, Clavo AC, Wahl RL. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med. 1993;34:414–9.PubMed Higashi K, Clavo AC, Wahl RL. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med. 1993;34:414–9.PubMed
Metadata
Title
Giant Cell Tumor with Secondary Aneurysmal Bone Cyst Shows Heterogeneous Metabolic Pattern on 18F-FDG PET/CT: A Case Report
Authors
Hee Jeong Park
Seong Young Kwon
Sang-Geon Cho
Jahae Kim
Ho-Chun Song
Sung Sun Kim
Yeon Hong Yoon
Jin Gyoon Park
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
Nuclear Medicine and Molecular Imaging / Issue 4/2016
Print ISSN: 1869-3474
Electronic ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-016-0423-z

Other articles of this Issue 4/2016

Nuclear Medicine and Molecular Imaging 4/2016 Go to the issue